KarenSofiaFernandezMD
Pediatric Hematology & Oncology • Madera, CACancer Genetics/Cancer Risk Assessment, Hospice and Palliative Medicine(Pediatric Hematology and Oncology), Pediatric Solid Tumor Oncology
Director Solid Tumor Program Clinical Associate Professor of Pediatrics Stanford Medicine
Dr. Fernandez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9300 Children's Place Drive
Madera, CA 93636Phone+1 559-353-5480- Is this information wrong?
Summary
- Dr. Karen Fernandez is a pediatric hematologist/oncologist in Madera, CA. She received her medical degree from Universidiad Francisco Marroquin Faculty of Medicine and has been in practice 16 years. She also speaks multiple languages, including Spanish. She specializes in hospice and palliative medicine(pediatric hematology and oncology), pediatric sarcoma oncology, and pediatric solid tumor oncology and is experienced in global health, healthcare quality, medical education, and neoplasm drug resistance.
Education & Training
Massachusetts General Hospital/Dana-Farber Cancer Institute/Brigham and Women's HospitalFellowship, Hospice and Palliative Medicine, 2012 - 2012
Nationwide Children's Hospital/Ohio State UniversityFellowship, Pediatric Hematology/Oncology, 2006 - 2009
University of Illinois College of Medicine at ChicagoResidency, Pediatrics, 2004 - 2006- University of Illinois College of Medicine at ChicagoInternship, Pediatrics, 2003 - 2004
Universidiad Francisco Marroquin Faculty of MedicineClass of 2001
Certifications & Licensure
CA State Medical License 2016 - 2024
IL State Medical License 2003 - 2017
OH State Medical License 2006 - 2011- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Hospice and Palliative Medicine
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
- Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma Start of enrollment: 2004 Sep 04
- Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma Start of enrollment: 2005 Nov 14
- Join now to see all
Publications & Presentations
PubMed
- Paraneoplastic juvenile idiopathic arthritis as a manifestation of a benign teratoma in a 5-year-old female.Shivani Kamal, Sukesh Sukumaran, Christopher LePhong, Karen S Fernandez> ;Pediatric Blood & Cancer. 2023 Oct 1
- Alveolar soft part sarcoma: Prolonged response to immune checkpoint inhibitors.Ruetima Titapiwatanakun, Crystal Farrell, Karen S Fernandez> ;Pediatric Blood & Cancer. 2023 May 12
- 1 citationsBrentuximab vedotin related neuropathy in a patient with Gilbert syndrome: Do mutations of UGT1A1 gene affect brentuximab toxicity?Nicole Diebert, Katherine Baker, Karen S. Fernández> ;Pediatric Blood & Cancer. 2021 Nov 12
- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Member
- American Society of Pediatric Hematology OncologyMember
- Children's Oncology GroupMember
- International Society of Pediatric Oncology (SIOP)Member
- Central American Asociation of Pediatric Oncology (AHOPCA)Member
Other Languages
- Spanish
External Links
- Valley Children's Hospitalhttp://Valleychildrens.org
- Childrens Hospital of Illinois http://www.childrenshospitalofillinois.org/services-and-clinics/specialty-services/hematology-oncology.html
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
